spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Cardiovascular Research Foundation 

 HSMN NewsFeed - 1 May 2023
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 14 Oct 2020
NuVera Medical Announces Positive Results From First-in-human Feasibility Study At 2020 TCT Conference
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Sep 2019
Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2019
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Nov 2016
Boston Scientific Announces Initial U.S. Commercial Performance Of The WATCHMAN(TM) Left Atrial Appendage Closure Device
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 12 Oct 2015
Abbott Announces Positive Clinical Results of Absorb(TM), the Naturally Dissolving Heart Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Mar 2015
Tryton Medical Announces Publication of Data from Pivotal Trial for Tryton Side Branch Stent in Journal of American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Sep 2014
Symetis Receives CE Mark Approval for Transfemoral Transcatheter Aortic Heart Valve System ACURATE neo(TM), and Launches Product With First Commercial Implantations
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 8 Sep 2014
Tryton Medical Completes $20 Million Equity Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 12 Dec 2013
St. Jude Medical Gains CE Mark for 25 mm Portico Transcatheter Aortic Heart Valve
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 4 Nov 2013
Supersaturated Oxygen Therapy IDE Study Results in Smaller Infarct Size for Next-Generation System
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2013
Cardiovascular Systems, Inc. Receives Coronary FDA Approval
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 17 Oct 2013
Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Jun 2013
AngioScore Announces Completion of Enrollment in Drug-Coated AngioSculpt(R) Scoring Balloon Catheter First-in-Human Study
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Mar 2013
Cordis Acquires Flexible Stenting Solutions, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 26 Nov 2012
Tryton Medical Announces Completion of Patient Enrollment in Landmark Pivotal Study of Side Branch Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Nov 2012
St. Jude Medical Announces European Approval of the Portico Transcatheter Aortic Heart Valve
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 Nov 2012
Largest Prospective Study Shows IVUS-Guided Stent Placement Improves Patient Outcomes with Current Generation of Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Nov 2012
S.M.A.R.T.(R) Vascular Stent Systems Receive FDA Approval for Use in SFA
Devices Interventional FDA
 HSMN NewsFeed - 23 Oct 2012
Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2012
The Boston Scientific Epic(TM) Stent Continues to Demonstrate Positive Clinical Outcomes for Patients with Iliac Artery Disease
Devices Interventional
 HSMN NewsFeed - 23 Oct 2012
The Boston Scientific PROMUS Element(TM) Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Oct 2012
SV Life Sciences and Third Rock Ventures Launch Transformative Medical Device Company Cibiem with $10 Million Series A
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 17 May 2012
Early Coronary Artery Healing Advantage of OrbusNeich's Combo Dual Therapy Stent(TM) Compared to the TAXUS(R) Stent Shown in Two Clinical Trial Subgroup Analyses
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Dec 2011
AngioScore Announces Successful Initiation of Enrollment in Drug-Coated AngioSculpt(R) Scoring Balloon Catheter First-in-Human Study
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Nov 2011
Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance(R) Drug Eluting Balloon with Paccocath(R) Technology to be Presented at 2011 TCT
Devices Interventional
 HSMN NewsFeed - 1 Nov 2011
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Feb 2011
REVA Expands Management Team With Key Executive Hire
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 15 Feb 2011
Boston Scientific Establishes Endowment for Donald S. Baim, M.D., Scholarship at Yale School of Medicine
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 26 Jan 2011
Tryton Announces Enrollment of First U.S. Patient in Pivotal Study of Side Branch Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Dec 2010
Tryton Announces Investigational Device Exemption Conditional Approval from FDA to Conduct U.S. Pivotal Study of Side Branch Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 23 Sep 2010
Abbott's XIENCE V(R) Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2010
Abbott's XIENCE V(R) Shows Outstanding Two-Year Clinical Results Versus TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Boston Scientific's TAXUS(R) Element Stent Demonstrates Strong Outcomes in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Long-Term Data Show Advantages for TAXUS(R) Liberte(R) Stent in Small Vessels and Long Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Sep 2010
Corindus Announces Results of First-in-Human Clinical Study of CorPath(R) 200 System
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Boston Scientific Announces CE Mark and FDA Approval of NC Quantum Apex Balloon Catheter
Devices FDA Interventional Cardiology Regulatory
 HSMN NewsFeed - 6 May 2010
The New England Journal of Medicine Publication of SPIRIT IV Trial Results Confirm Superior Safety and Efficacy of Abbott's XIENCE V(R) Drug Eluting Stent Compared to TAXUS
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Nov 2009
Cappella, Inc. Announces Initiation of Sideguard 3
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Sep 2009
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2009
Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2009
Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
Devices Cardiology
 HSMN NewsFeed - 23 Sep 2009
FAME Trial Two-Year Follow-Up Results Demonstrate Continued Reduction in Risk of Death or Heart Attack When Physicians Use St. Jude Medical Fractional Flow Reserve Technology Prior to Implanting Coronary Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
TAXUS(R) Liberte(R) Stent Continues to Demonstrate Significant Improvements Over TAXUS(R) Express(R) Stent in Small Vessels and Long Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 12 May 2009
Enrollment Complete in the XCELL Trial - The First U.S. Study of Stent Placement to Study Arterial Blockages Below the Knee
Devices Interventional
 HSMN NewsFeed - 9 Apr 2009
New Clinical Data at ACC09 Show the CYPHER Sirolimus-eluting Coronary Stent Outperformed TAXUS LIBERTE and ENDEAVOR Stents in Key Outcome Measures
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Feb 2009
Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Jan 2009
Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Oct 2008
TAXUS OLYMPIA Registry Shows Excellent Outcomes for High-Risk Patients Treated with Second-Generation TAXUS(R) Liberte(R) Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Oct 2008
Endeavor(R) Vs. Taxus(R): Medtronic's Drug-Eluting Coronary Stent Linked to Fewer Heart Attacks at Two Years Post Implant
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
New Data Shows Abbott's Bioabsorbable Drug Eluting Stent is Absorbed Within Two Years - Leaving Behind Functioning Blood Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2008
TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2008
Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Oct 2008
W. L. Gore & Associates Receives FDA Approval for Gore EMBOLDEN Clinical Study
Devices FDA Interventional
 HSMN NewsFeed - 7 Oct 2008
CeloNova BioSciences to Showcase the CE-Marked CATANIA(TM) Coronary Stent System Featuring NanoThin Polyzene(R)-F at TCT Debut
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Sep 2008
Boston Scientific Announces FDA Approval of TAXUS(R) Express2(TM) Atom(TM) Stent System, First Drug-Eluting Stent For Small Vessels
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 28 Aug 2008
The CYPHER(R) Sirolimus-eluting Coronary Stent Outperforms the Taxus(R) Stent in People with Diabetes According to Clinical Data in the Journal of the American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Jul 2008
FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 29 May 2008
Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 19 May 2008
Volcano Announces Acquisition of Novelis, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 13 May 2008
SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
St. Jude Medical Announces Start of Landmark DETERMINE ICD Study
Devices Cardiology
 HSMN NewsFeed - 22 Apr 2008
Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Angiomax Demonstrated Improved Outcomes in Acute Heart Attack Patients Undergoing Primary Angioplasty Independent of Individual Risk Factors
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 4 Mar 2008
MIV Therapeutics Announces Changes to Its Scientific Advisory Board
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 1 Feb 2008
Medtronic Receives FDA Approval for Endeavor(R) Zotarolimus-Eluting Coronary Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Dec 2007
Texas Heart Institute at St. Luke's Episcopal Hospital Participates in Ground-Breaking Heart Recovery Technology Study
Devices Cardiology
 HSMN NewsFeed - 29 Nov 2007
FDA Advisory Committee Recommends Approval of Abbott's XIENCE(TM) V Drug Eluting Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Nov 2007
Abbott to Present Comprehensive Safety and Efficacy Data on XIENCE(TM) V Drug Eluting Stent to FDA Advisory Committee on Nov. 29
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Nov 2007
At TCT 2007, Cappella Demonstrates Procedural Advantages and Clinical Benefits of Its Technology in Treating Coronary Bifurcations
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2007
Drug Eluting Balloons Show Promise as a Potential Alternative to Drug Eluting Stents Used in the Treatment of Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2007
CoreValve's 18-French ReValving(TM) System for percutaneous aortic valve replacement (PAVR) demonstrated 'live' at TCT 2007
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2007
Safety Profile of Medtronic's Endeavor(R) Drug-Eluting Stent Affirmed in Comprehensive Data Analysis
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2007
New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Oct 2007
Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery
Devices Interventional
 HSMN NewsFeed - 23 Oct 2007
Medtronic Trials Confirm Ability of Interceptor(R) Coronary Filter System and Export(R) Aspiration Catheter to Reduce Major Cardiac Events
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2007
Edwards' Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
Devices Interventional
 HSMN NewsFeed - 23 Oct 2007
TherOx(TM) AMIHOT II Pivotal Trial Meets Endpoints
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Endeavor Clinical Program Continues to Provide Positive Safety and Efficacy Data
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Elixir Medical Announces Positive Clinical Results for the Company's First Drug Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
PLC Medical Systems to Introduce RenalGuard(TM) at TCT 2007
Devices Interventional
 HSMN NewsFeed - 22 Oct 2007
XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Oct 2007
Results of First-In-Man Study With MIVT Low Dose Polymer-Free Drug-Eluting Stent to Be Presented at TCT Conference
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Jun 2007
Abbott Submits XIENCE(TM) V Everolimus Eluting Coronary Stent System Application for U.S. FDA Approval
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
SPIRIT Clinical Data Reaffirm Strength of TAXUS(R) and PROMUS(TM) Drug-Eluting Coronary Stent Systems
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
Abbott Announces Continued Positive Results with XIENCE(TM) V Everolimus Eluting Coronary Stent in SPIRIT Clinical Trials
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Apr 2007
COURAGE, SPIRIT Data May Support Role of Advanced Imaging and Diagnosis With IVUS and FFR
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Apr 2007
Volcano Corporation Reports Use of IVUS Increasing as Physicians Refocus on Stent Technique
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Mar 2007
CYPHER(R) Sirolimus-eluting Coronary Stent Demonstrates Sustained Benefits Compared to Bare-Metal Stents in Five-Year Randomized Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2007
Two-Year Patient Registry Results Support Safety and Efficacy of CYPHER(R) Sirolimus-Eluting Coronary Stent in 'Real World' Uses
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2007
ACUITY One-Year Findings Meet All Primary Endpoints in Favor of Angiomax(R) (Bivalirudin) Alone Treatment Group
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 24 Mar 2007
Spirit III Clinical Trial Demonstrates Positive Performance for Both TAXUS(R) and PROMUS(TM) Drug-Eluting Stent Systems
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2007
Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Superior to TAXUS(R) Stent in SPIRIT III U.S. Pivotal Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Jan 2007
AngioScore Receives Premarket Approval (PMA) for AngioSculpt(R) Scoring Balloon Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 7 Dec 2006
Volcano Corporation Announces Collaboration With Stanford University, Cardialysis and Cardiovascular Research Foundation Core Labs to Facilitate In-Depth IVUS Studies of Drug Eluting Stent Safety and Performance
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Dec 2006
Radiant Medical Trial Shows Promising Results in Preventing Kidney Damage
Devices
 HSMN NewsFeed - 22 Nov 2006
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Nov 2006
Medtronic Submits Final PMA Modules to FDA for Approval of the Endeavor Drug-Eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Oct 2006
TAXUS(R) stents demonstrate excellent efficacy and safety in studies presented at TCT 2006
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2006
Medtronic Announces Positive Results for Endeavor RESOLUTE Drug-Eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2006
Safety and Efficacy Benefits of Next-Generation TAXUS(R) Liberte(TM) Stent Sustained at Twelve Months
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2006
Data in Complex Patients and Lesions from OLYMPIA Registry Support Safety and Efficacy of TAXUS(R) Liberte(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Oct 2006
Dr. Ron Waksman to Discuss Details of First US Coronary Remote Control Catheterization Trial (CORRECT) at TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
CoreValve's 18-French Revalving(TM) System Demonstrated 'Live' at TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
Cordis to Study Impact of Contributing Factors to Stent Thrombosis in Expansion of 30,000-Stent Patient Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
Data Presented by Independent Physician Panel Confirms Low Rate of Thrombosis with Medtronic Endeavor Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Oct 2006
Radiant Medical Initiates Clinical Trial of Therapeutic Cooling for Kidney Protection
Devices
 HSMN NewsFeed - 24 Oct 2006
Independent Meta-Analysis Confirms Safety and Efficacy of TAXUS Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2006
Boston Scientific Reports Positive Results for its Carotid Artery Stenting Trial
Devices Interventional
 HSMN NewsFeed - 23 Oct 2006
Boston Scientific to Support Landmark STENT Thrombosis Study
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2006
New Study Shows Prasugrel Achieves Faster Onset and Higher Levels of Platelet Inhibition than Clopidogrel at Approved or Higher Doses
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 Oct 2006
Caritas St. Elizabeth's Medical Center's Study Finds Injecting Patient's Own Stem Cells into the Heart to Treat Severe Coronary Artery Disease is Well Tolerated
Biopharmaceuticals Regenerative Medicine Cardiology
 HSMN NewsFeed - 23 Oct 2006
MIV Therapeutics to Detail Research Results Showing Excellent Performance of Breakthrough Stent Coatings at TCT Conference
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2006
ev3 Inc. Issues Durability Guarantee for its EverFlex(TM) Self-Expanding Stents
Devices Interventional
 HSMN NewsFeed - 20 Oct 2006
Volcano Corporation and MediGuide Ltd. Announce Collaboration for Advanced Imaging and Navigation Technology
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Oct 2006
Corindus to Unveil CorPath(TM) its Remote Controlled Angioplasty System at TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Oct 2006
Genesis Medical Interventional to Launch F.A.S.T.(TM) Funnel Catheter(TM) at Upcoming TCT Meeting October 23 in Washington, DC.
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Oct 2006
Boston Scientific to Highlight Broad Range of Clinical Trial Results Reinforcing Safety and Efficacy of TAXUS(R) Coronary Stent Systems at TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Oct 2006
Abbott to Present New Data Across Its Vascular Portfolio at TCT 2006
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Sep 2006
First Patient Enrolled in First U.S. Study of Stent Placement to Treat Blockages Below the Knee
Devices Interventional
 HSMN NewsFeed - 16 May 2006
X-Cell Medical Completes Enrollment for Clinical Trial of ETHOS II Estradiol Eluting Stent
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 77

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 77 additional stories matching:
Cardiovascular Research Foundation
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.